Printer Friendly

CORDIS' SLEEK CATHETER RECEIVES "APPROVABLE LETTER"

 MIAMI, May 3 /PRNewswire/ -- Cordis Corporation (NASDAQ-NMS: CORD) said today that the Food and Drug Administration has issued an "approvable letter" on the company's most advanced balloon angioplasty catheter to date: Sleek PTCA Dilatation Catheter. Actual market release must await the review of additional data, information the company said it is in a position to provide by Friday (May 7) of this week.
 Robert C. Strauss, president and chief executive officer, called the action significant. "Naturally," he said, "we would have liked to been able to launch Sleek in the US immediately, but in today's difficult regulatory environment, Cordis is fortunate indeed. We intend to immediately accelerate production and sales training so that when final approval is received, the company will be positioned to act."
 Like other angioplasty devices, Sleek over-the-wire catheters help open coronary arteries occluded by the buildup of fatty deposits, or plaque, associated with atherosclerosis. Sleek catheters, however, which can accommodate up to an .014 guidewire, offer high performance with some of the lowest profiles in the industry. In fact, their profiles rival those of even the lowest fixed-wire catheters, a feature that enables doctors to treat particularly tortuous and distal lesions.
 Cordis said that Sleek catheter sales have been strong for several months in Japan, Canada and, most recently, Europe. The device is expected to be a major contributor to the company's steadily improving angioplasty position in the large US market.
 Miami-based Cordis Corporation manufactures and markets a variety of medical devices and systems for the angiographic and neuroscience markets.
 -0- 5/3/93
 /CONTACT: Chick McDowell, vice president, corporate relations and assistant secretary of Cordis Corporation, 305-824-2821/
 (CORD)


CO: Cordis Corporation ST: Florida IN: MTC SU:

JB-AW -- FL015 -- 3964 05/03/93 16:29 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 3, 1993
Words:290
Previous Article:FISCHER IMAGING ACQUIRES X-RAY SUBSYSTEMS PRODUCT LINES FROM VARIAN ASSOCIATES....AND INVESTS IN TETRAD
Next Article:THREE-WAY PARTNERSHIP FORMS TO BRINGMULTIPLEX THEATERS TO NETHERLANDS
Topics:


Related Articles
CORDIS' SLEUTH ANGIOPLASTY CATHETER GAINS MARKET APPROVAL
CORDIS' ORION SOFT TIP ANGIOPLASTY CATHETER GAINS MARKET APPROVAL
FOUR CORDIS ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
CORDIS ANNOUNCES SLEEK LONG BALLOON CATHETERS APPROVED FOR U.S. MARKET RELEASE
ANOTHER CORDIS ANGIOPLASTY CATHETER APPROVED FOR US MARKET RELEASE
CORDIS PREDATOR LONG BALLOON CATHETERS APPROVED FOR U.S. MARKET RELEASE
CORDIS TRAKSTAR ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
CORDIS GAINS FDA APPROVAL FOR FOUR NEW ANGIOPLASTY CATHETERS
CORDIS RECEIVES LETTER FROM FDA
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters